Esperion Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, everyone, and welcome to -- welcome as we continue the 40th Annual JPMorgan Healthcare Conference. My name is Nick Lenard. I'm a biotech analyst here at JPMorgan. I'm joined here today by Esperion's President and CEO, Sheldon Koenig, and other members of management who will provide a presentation of the company, followed by a short Q&A session. (Operator Instructions) I'll receive your questions and be happy to ask management on your behalf.
And now happy to turn it over to Sheldon for the presentation.
Great. Thank you, Nick. Really appreciate it. It's good to see you today and great to speak to everyone who's attending. On behalf of Esperion Therapeutics, it's our pleasure to have this opportunity to present at the JPMorgan conference. I think we're all ready to head to San Francisco. But hopefully, next year, we'll be doing this live from San Francisco. So thank you
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |